Inhibikase Therapeutics, Inc. (IKT) Earnings
NASDAQ·Healthcare·Biotechnology
$2.17
-6.28%
Mkt Cap $303.68M
EPS — Estimate vs Actual
Mkt Cap
$303.68M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.54
NASDAQ·Healthcare·Biotechnology
$2.17
-6.28%
Mkt Cap $303.68M
Mkt Cap
$303.68M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.54